You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (37) |
Back to Search
immunology and related genetic factors of fluoroquinolone-induced liver injury
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-HPS-050
- By: YANG, Hongyi (Chinese People's Liberation Army General Hospital, Department of Pharmaceutical Care, China)
- Co-author(s): Hongyi Yang: Department of Pharmaceutical Care, Chinese People's Liberation Army General Hospital, Beijing, China
Daihong Guo: Department of Pharmaceutical Care, Chinese People's Liberation Army General Hospital, Beijing, China
Yuanjie Xu: Department of Pharmaceutical Care, Chinese People's Liberation Army General Hospital, Beijing, China
Chong Yao: Department of Pharmaceutical Care, Chinese People's Liberation Army General Hospital, Beijing, China
Wangping Jia: Department of Pharmaceutical Care, Chinese People's Liberation Army General Hospital, Beijing, China
Xianghao Kong: Department of Pharmaceutical Care, Chinese People's Liberation Army General Hospital, Beijing, China - Abstract:
Background
Drug-induced liver injury (DILI) is a frequent adverse drug reaction (ADR) that may present multiple clinical manifestations and is also one of the most frequent reasons for drug non-approval or withdrawal from market. Unfortunately, the mechanism underlying DILI is not well understood. Immune and genetic factors have always been.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026